Literature DB >> 3300536

Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans.

J E Domer, R F Hector.   

Abstract

Immune consequences of gastrointestinal colonization of CD-1 and CBA/J mice with Candida albicans in the presence or absence of continuous antibiotic treatment with penicillin-tetracycline or trimethoprimsulfamethoxazole were investigated. Intubation with C. albicans in the absence of antibiotics resulted in the induction of low but detectable delayed-type hypersensitivity (DTH), demonstrable by footpad testing with a C. albicans wall glycoprotein (GP), and in the stimulation of a moderate level of protective immunity, demonstrable by intravenous (i.v.) challenge. DTH to a membrane extract, BEX, could not be detected in such animals. However, animals colonized in the presence of antibiotics and then inoculated cutaneously prior to being tested for DTH or protective immunity developed significantly enhanced levels of DTH to GP and BEX and were protected to an even greater extent than animals colonized in the absence of antibiotics who were not inoculated cutaneously. The priming effect of colonization, particularly with respect to the antigen GP, was also obvious from an enzyme-linked immunosorbent assay for GP-specific antibody with sera of mice surviving the i.v. challenge, in that GP-specific antibody was present in the highest titers in colonized animals that had been inoculated cutaneously prior to i.v. challenge. While the antibiotics promoted higher levels of colonization, as evidenced by stomach and fecal cultures of intubated mice, antibiotic administration was not necessary for the induction of C. albicans-specific responses. Moreover, contrary to reports in the literature, antibiotic administration had no adverse effect on the immune responses measured. Females were innately more resistant than males to i.v. challenge with C. albicans, but each sex was capable of developing protective immunity of equal intensity in response to colonization or immunization by cutaneous challenge.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300536      PMCID: PMC174816          DOI: 10.1128/AAC.31.5.691

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Enhancement of Candida infection: differential distribution of renal lesions in mice treated with aureomycin.

Authors:  W D WINTER; G E FOLEY
Journal:  J Infect Dis       Date:  1956 Mar-Apr       Impact factor: 5.226

2.  Virulence enhancement of Candida albicans by antibiotics and cortisone.

Authors:  E SELIGMANN
Journal:  Proc Soc Exp Biol Med       Date:  1953 Aug-Sep

3.  Antibiotics and suppression of lymphocyte function in vitro.

Authors:  G Banck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

Review 4.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

Review 5.  Effect of antibiotics on the immune response.

Authors:  W E Hauser; J S Remington
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

6.  Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.

Authors:  J E Domer; S A Moser
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

7.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Effect of tetracycline treatment on immunological responses in mice.

Authors:  Y H Thong; A Ferrante
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis.

Authors:  A Restrepo; M E Salazar; L E Cano; E P Stover; D Feldman; D A Stevens
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Inhibition by sulfonamides of the candidacidal activity of human neutrophils.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  14 in total

1.  Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Authors:  Ronen Ben-Ami; Keren Olshtain-Pops; Michal Krieger; Ilana Oren; Jihad Bishara; Michael Dan; Yonit Wiener-Well; Miriam Weinberger; Oren Zimhony; Michal Chowers; Gabriel Weber; Israel Potasman; Bibiana Chazan; Imad Kassis; Itamar Shalit; Colin Block; Nathan Keller; Dimitrios P Kontoyiannis; Michael Giladi
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Antibiotic administration alleviates the aggravating effect of orthodontic force on ligature-induced experimental periodontitis bone loss in mice.

Authors:  J Shi; Z Liu; T Kawai; Y Zhou; X Han
Journal:  J Periodontal Res       Date:  2017-02-18       Impact factor: 4.419

3.  Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice.

Authors:  E Balish; H Filutowicz; T D Oberley
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.

Authors:  R E Garner; U Kuruganti; L A al-Hussaini; C W Czarniecki; J E Domer
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Mucosal and systemic candidiasis in congenitally immunodeficient mice.

Authors:  M T Cantorna; E Balish
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

6.  Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans.

Authors:  G Samonis; H Anastassiadou; M Dassiou; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

7.  Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.

Authors:  R E Garner; J E Domer
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.

Authors:  J E Domer; L G Human; G B Andersen; J A Rudbach; G L Asherson
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.

Authors:  R E Garner; U Kuruganti; C W Czarniecki; H H Chiu; J E Domer
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Massive fungal contamination in animal care facilities traced to bedding supply.

Authors:  P Mayeux; L Dupepe; K Dunn; J Balsamo; J Domer
Journal:  Appl Environ Microbiol       Date:  1995-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.